Preliminary Evaluation of the Safety, Pharmacokinetics, and Clinical Application of 18F-CP6A PET Imaging in Synucleinopathies
Latest Information Update: 21 Feb 2025
At a glance
- Drugs 18F CP6A (Primary)
- Indications Neurodegenerative disorders
- Focus Pharmacokinetics
Most Recent Events
- 21 Feb 2025 New trial record